For The Better

The stock’s valuation might underestimate how IAC can perform in a stronger advertising market.

Want to play chess on Wall Street with the Oracle of Omaha? Learn how to strategize like a grandmaster in the game of stocks.

Nikola helped analysts with insights into what’s going on inside the company.

Polygon’s all-time high once teased investors with the promise of $10 per token. Is that dream still within reach? Dive into an analysis of MATIC’s potential in the ever-evolving crypto landscape.

The company got bad news from the FDA and saw increased losses.

The stock ran too high too fast last month, and some are booking profits now.

The company’s second-quarter report showed a big revenue surge.

Is Maxeon getting bigger at the exact wrong time for solar stocks?

The growth-focused money manager has been selling some shares of her best-performing stocks of 2023.

The biotech is out to prove that it isn’t just a “pandemic stock.”

Tesla investors should get excited about its future in the European market.

Pfizer is a well-known name in the pharmaceutical industry.

These two stocks look like bargains right now for income investors.

The world’s most-visited theme park hopes a popular seasonal event can turn around what was an initially disappointing summer.

Nvidia is reportedly seeing a massive influx of orders for its AI chips from top Chinese tech giants.

Until it can get some recurring revenue going, it’ll be a risky stock to buy.

This hot AI stock may have risen too far too fast this year.

Its shares tumbled due to factors outside its control, but the biotech still has substantial long-term potential.

One’s soaring, and one’s plunging.

The Tilray of today is very different from a mere two years ago.